Skip to main content

Table 1 Demographic, clinical and functional characteristics of the patients included in the study

From: Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis

Variable

IPF (n = 22)

NSIP (n = 10)

p value

Male/Female (% males)

17/5 (77%)

2/8 (20%)

0.0051

Age (years)

62 ± 6

45 ± 11

< 0.0001

BMI (m/Kg2)

26 ± 5

24 ± 3

n.s.

mPAP (mmHg)+

29 ± 12

35 ± 21

n.s.

6MWD (m)

293 ± 103

292 ± 195

n.s.

FVC (% pred)

57 ± 19

49 ± 18

n.s.

TLC (% pred)

65 ± 14

65 ± 18

n.s.

DLCO (% pred)

37 ± 10

51 ± 18

0.0242

Treatment (% of total):

 Prednisone alone

7 (31.8%)

5 (50%)

n.s.

 Prednisone + Azathioprine

8 (36.4%)

2 (20%)

n.s.

 NAC alone

1 (4.5%)

0 (0%)

n.s.

 No specific treatment

6 (27.3%)

3 (30%)

n.s.

  1. +intraoperative mPAP during lung transplant
  2. IPF idiopathic pulmonary fibrosis, NSIP non-specific interstitial pneumonia, BMI body mass index, mPAP mean pulmonary arterial pressurem, 6MWD 6-min walk distance, FVC forced vital capacity, TLC total lung capacity, DLCO diffusing lung capacity for carbon monoxide, n.s. not significant